Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

The occurrence of SOX2-specific autoantibodies seems to be associated with an improved prognosis in patients with monoclonal gammopathy of undetermined significance (MGUS). However, it is unclear if SOX2-specific antibodies also develop in established multiple myeloma (MM). Screening 1094 peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobold, Sebastian, Tams, Sinje, Luetkens, Tim, Cao, Yanran, Sezer, Orhan, Bartels, Britta Marlen, Reinhard, Henrike, Templin, Julia, Bartels, Katrin, Hildebrandt, York, Lajmi, Nesrine, Marx, Andreas, Haag, Friedrich, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227434/
https://www.ncbi.nlm.nih.gov/pubmed/22190969
http://dx.doi.org/10.1155/2011/302145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227434/
https://www.ncbi.nlm.nih.gov/pubmed/22190969
http://dx.doi.org/10.1155/2011/302145

Ejemplares similares